Cardiac myofilament regulation by protein phosphatase type 1α and CapZ

Biochemistry and Cell Biology

Volumn 86, Issue 1, 2008, Pages 70-78

  Yang, Fenghua ^a   Aiello, David L ^a   Pyle, W Glen ^a,b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

CapZ; Cardiac myofilaments; Protein phosphatase 1

Indexed keywords

CARDIAC MYOFILAMENTS; MYOFILAMENTS; PROTEIN KINASES; PROTEIN PHOSPHATASE;

BINDING SITES; CARDIOLOGY; GENE EXPRESSION; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ENZYME ACTIVITY;

ADENOSINE TRIPHOSPHATASE; CALCIUM; MAGNESIUM; MYOSIN BINDING PROTEIN C; MYOSIN LIGHT CHAIN 2; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1ALPHA; PROTEIN CAPZ; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE CONTROL; IMMUNOCHEMISTRY; MYOFILAMENT; NONHUMAN; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION;

ACTOMYOSIN; ANIMALS; CA(2+) MG(2+)-ATPASE; CAPZ ACTIN CAPPING PROTEIN; FEMALE; MICE; MICE, INBRED C57BL; MICROFILAMENTS; MYOCARDIUM; PROTEIN PHOSPHATASE 1; SIGNAL TRANSDUCTION;

MURINAE;

EID: 39049145585     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O07-150     Document Type: Article

References (28)

1. Brenner, B. 1991. Rapid dissociation and reassociation of actomyosin cross-bridges during force generation: a newly observed facet of cross-bridge action in muscle. Proc. Natl. Acad. Sci. U.S.A. 88: 10490-10494. doi:10.1073/pnas.88.23.10490.
2. Carr, A.N., Schmidt, A.G., Suzuki, Y., del Monte, F., Sato, Y., Lanner, C., et al. 2002. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22: 4124-4135. doi:10.1128/MCB.22.12.4124-4135.2002.
3. Coghlan, V.M., Perrino, B.A., Howard, M., Langeberg, L.K., Hicks, J.B., Gallatin, W.M., et al. 1995. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science, 267: 108-111. doi:10.1126/science.7528941.
4. de Tombe, P.P. 1998. Altered contractile function in heart failure. Cardiovasc. Res. 37: 367-380. doi:10.1016/S0008-6363(97)00275-7.
5. de Tombe, P.P., and Solaro, R.J. 2000. Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure. Ann. Biomed. Eng. 28: 991-1001. doi:10.1114/1.1312189.
6. Frey, N., and Olson, E.N. 2002. Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J. Biol. Chem. 277: 13998-14004. doi:10.1074/jbc.M200712200.
7. Gupta, R.C., Mishra, S., Rastogi, S., Imai, M., Habib, O., and Sabbah, H.N. 2003. Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts. Am. J. Physiol. Heart Circ. Physiol. 285: H2373-H2381.
8. Gupta, R.C., Mishra, S., Yang, X.P., and Sabbah, H.N. 2005. Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats. Mol. Cell. Biochem. 269: 49-57. doi:10.1007/s11010-005-2538-x.
9. Hart, M.C., and Cooper, J.A. 1999. Vertebrate isoforms of actin capping protein beta have distinct functions in vivo. J. Cell Biol. 147: 1287-1298. doi:10.1083/jcb.147.6.1287.
10. Heiss, S.G., and Cooper, J.A. 1991. Regulation of CapZ, an actin capping protein of chicken muscle, by anionic phospholipids. Biochemistry, 30: 8753-8758. doi:10.1021/bi00100a006.
11. Khaitlina, S., and Hinssen, H. 1997. Conformational changes in actin induced by its interaction with gelsolin. Biophys. J. 73: 929-937.
12. Mittmann, C., Eschenhagen, T., and Scholz, H. 1998. Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc. Res. 39: 267-275. doi:10.1016/S0008-6363(98)00139-4.
13. 2+ desensitisation in skinned murine myocardium. Cardiovasc. Res. 74: 124-132. doi:10.1016/j.cardiores.2007. 01.019.
14. Neumann, J., Eschenhagen, T., Jones, L.R., Linck, B., Schmitz, W., Scholz, H., et al. 1997. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29: 265-272. doi:10.1006/jmcc.1996.0271.
15. Noland, T.A., Jr., Raynor, R.L., Jideama, N.M., Guo, X., Kazanietz, M.G., Blumberg, P.M., et al. 1996. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry, 35: 14923-14931. doi:10.1021/bi9616357.
16. Pathak, A., del Monte, F., Zhao, W., Schultz, J.E., Lorenz, J.N., Bodi, I., et al. 2005. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ. Res. 96: 756-766. doi:10.1161/01.RES.0000161256.85833.fa.
17. Patton, C., Thompson, S., and Epel, D. 2004. Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium, 35: 427-431. doi:10.1016/j.ceca.2003.10.006.
18. Prochniewicz, E., Zhang, Q., Janmey, P.A., and Thomas, D.D. 1996. Cooperativity in F-actin: binding of gelsolin at the barbed end affects structure and dynamics of the whole filament. J. Mol. Biol. 260: 756-766. doi:10.1006/jmbi.1996.0435.
19. Pyle, W.G., and Solaro, R.J. 2004. At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ. Res. 94: 296-305. doi:10.1161/01.RES. 0000116143.74830.A9.
20. Pyle, W.G., Smith, T.D., and Hofmann, P.A. 2000. Cardioprotection with kappa-opioid receptor stimulation is associated with a slowing of cross-bridge cycling. Am. J. Physiol. Heart Circ. Physiol. 279: H1941-H1948.
21. Pyle, W.G., Hart, M.C., Cooper, J.A., Sumandea, M.P., de Tombe, P.P., and Solaro, R.J. 2002. Actin capping protein: an essential element in protein kinase signaling to the myofilaments. Circ. Res. 90: 1299-1306. doi:10.1161/01.RES.0000024389.03152.22.
22. II signaling through the actin capping protein, CapZ. J. Mol. Cell. Cardiol. 41: 537-543. doi:10.1016/j.yjmcc.2006.06.006.
23. Rarick, H.M., Opgenorth, T.J., von Geldern, T.W., Wu-Wong, J.R., and Solaro, R.J. 1996. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity. J. Biol. Chem. 271: 27039-27043. doi:10.1074/jbc.271.43.27039.
24. Schonberger, J., and Seidman, C.E. 2001. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am. J. Hum. Genet. 69: 249-260. doi:10.1086/321978.
25. Seidman, C.E., and Seidman, J.G. 1998. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res. Cardiol. 93(Suppl 3): 13-16. doi:10.1007/s003950050196.
26. Steinberg, S.F., and Brunton, L.L. 2001. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 41: 751-773. doi:10.1146/annurev.pharmtox.41.1.751.
27. 2+ -sensitivity of force is enhanced in failing human hearts. Cardiovasc. Res. 57: 505-514. doi:10.1016/S0008-6363(02)00662-4.
28. Vondriska, T.M., Pass, J.M., and Ping, P. 2004. Scaffold proteins and assembly of multiprotein signaling complexes. J. Mol. Cell. Cardiol. 37: 391-397. doi:10.1016/j.yjmcc.2004.04.021.